The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study
Open accessAbstract
BACKGROUND: The Middle East respiratory syndrome coronavirus (MERS-CoV) has been reported to have a high case-fatality rate. Currently, there is no specific therapy or vaccine with proven effectiveness for MERS-CoV infections. METHODS: A combination of ribavirin and interferon therapy was used for the treatment of five MERS-CoV-positive patients. We reviewed the therapeutic schedule and the outcome of these patients. RESULTS: All patients were critically ill with acute respiratory distress syndrome treated with adjunctive corticosteroids and were on mechanical ventilation at the time of initiation of therapy. The median time from admission to therapy with ribavirin and interferon was 19 (range 10-22) days. None of the patients responded to the supportive or therapeutic interventions and all died of their illness. CONCLUSIONS: While ribavirin and interferon may be effective in some patients, our practical experience suggests that critically ill patients with multiple comorbidities who are diagnosed late in the course of their illness may not benefit from combination antiviral therapy as preclinical data suggest. There is clearly an urgent need for a novel effective antiviral therapy for this emerging global threat.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,735
Peiris, J., Chu, C., Cheng, V., Chan, K., Hung, I., Poon, L., Law, K., Tang, B., Hon, T., Chan, C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13412-5 · Cited by 2,375
Assiri, A., Al-Tawfiq, J. A., Al-Rabeeah, A. A., Al-Rabiah, F. A., Al-Hajjar, S., Al-Barrak, A., Flemban, H., Al-Nassir, W. N., Balkhy, H. H., Al-Hakeem, R. F., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70204-4 · Cited by 1,435
Self-citationHospital outbreak of Middle East respiratory syndrome coronavirus
Assiri, A., McGeer, A., Perl, T. M., Price, C. S., Al Rabeeah, A. A., Cummings, D. A. T., Alabdullatif, Z. N., Assad, M., Almulhim, A., Makhdoom, H., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1306742 · Cited by 1,196
Self-citationIdentification of Severe Acute Respiratory Syndrome in Canada
Poutanen, S. M., Low, D. E., Henry, B., Finkelstein, S., Rose, D., Green, K., Tellier, R., Draker, R., Adachi, D., Ayers, M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030634 · Cited by 1,132
A Cluster of Cases of Severe Acute Respiratory Syndrome in Hong Kong
Tsang, K. W., Ho, P. L., Ooi, G. C., Yee, W. K., Wang, T., Chan-Yeung, M., Lam, W. K., Seto, W. H., Yam, L. Y., Cheung, T. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030666 · Cited by 1,017
Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction
Corman, V. M., Eckerle, I., Bleicker, T., Zaki, A., Landt, O., Eschbach-Bludau, M., van Boheemen, S., Gopal, R., Ballhause, M., Bestebroer, T. M., et al. (2012) · Eurosurveillance · doi:10.2807/ese.17.39.20285-en · Cited by 561
Family Cluster of Middle East Respiratory Syndrome Coronavirus Infections
Memish, Z. A., Zumla, A. I., Al-Hakeem, R. F., Al-Rabeeah, A. A., & Stephens, G. M. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1303729 · Cited by 493
Self-citationTreatment with interferon-α2b and ribavirin improves outcome in MERS-CoV–infected rhesus macaques
Falzarano, D., de Wit, E., Rasmussen, A. L., Feldmann, F., Okumura, A., Scott, D. P., Brining, D., Bushmaker, T., Martellaro, C., Baseler, L., et al. (2013) · Nature Medicine · doi:10.1038/nm.3362 · Cited by 445
Zhao, Z. (2003) · Journal of Medical Microbiology · doi:10.1099/jmm.0.05320-0 · Cited by 407
Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus
Chan, J. F. W., Chan, K.-H., Kao, R. Y. T., To, K. K. W., Zheng, B.-J., Li, C. P. Y., Li, P. T. W., Dai, J., Mok, F. K. Y., Chen, H., et al. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.09.029 · Cited by 385
Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections
Corman, V. M., Müller, M. A., Costabel, U., Timm, J., Binger, T., Meyer, B., Kreher, P., Lattwein, E., Eschbach-Bludau, M., Nitsche, A., et al. (2012) · Eurosurveillance · doi:10.2807/ese.17.49.20334-en · Cited by 360
Hsu, L.-Y., Lee, C.-C., Green, J. A., Ang, B., Paton, N. I., Lee, L., Villacian, J. S., Lim, P.-L., Earnest, A., & Leo, Y.-S. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0906.030264 · Cited by 283
Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin
Falzarano, D., de Wit, E., Martellaro, C., Callison, J., Munster, V. J., & Feldmann, H. (2013) · Scientific Reports · doi:10.1038/srep01686 · Cited by 273
(2013) · Color Atlas of Cerebral Revascularization: Anatomy, Techniques, Clinical Cases · doi:10.1055/b-0034-92112 · Cited by 258
Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak
Sung, J. J. Y. (2004) · Thorax · doi:10.1136/thx.2003.014076 · Cited by 185
Omrani, A. S., Matin, M. A., Haddad, Q., Al-Nakhli, D., Memish, Z. A., & Albarrak, A. M. (2013) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2013.07.001 · Cited by 175
Self-citationAdisasmito, W., Chan, P. K. S., Lee, N., Oner, A. F., Gasimov, V., Aghayev, F., Zaman, M., Bamgboye, E., Dogan, N., Coker, R., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/656316 · Cited by 161
Momattin, H., Mohammed, K., Zumla, A. I., Memish, Z. A., & Al‐Tawfiq, J. A. (2013) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2013.07.002 · Cited by 154
Self-citationb Middle East respiratory syndrome coronavirus (MERS-CoV): update
Emirates, U. A. (2014) · Cited by 120
Lee, C. U., & Glockner, J. F. (2014) · Oxford University Press eBooks · doi:10.1093/med/9780199915705.003.0034 · Cited by 119
Middle East Respiratory Syndrome coronavirus (MERS CoV): Update 2013
Lim, P. L., Lee, T. H., & Rowe, E. K. (2013) · Current Infectious Disease Reports · doi:10.1007/s11908-013-0344-2 · Cited by 90
Taking stock of the first 133 MERS coronavirus cases globally – Is the epidemic changing?
Penttinen, P. M., Kaasik-Aaslav, K., Friaux, A., Donachie, A., Súdre, B., Amato‐Gauci, A. J., Memish, Z. A., & Coulombier, D. (2013) · Eurosurveillance · doi:10.2807/1560-7917.es2013.18.39.20596 · Cited by 73
Self-citationLeong, H. N., Ang, B. S. P., Earnest, A., Teoh, C., Xu, W., & Leo, Y. (2004) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2004.01281.x · Cited by 44
Cited by
SARS and MERS: recent insights into emerging coronaviruses
de Wit, E., van Doremalen, N., Falzarano, D., & Munster, V. J. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.81 · Cited by 3,510
Channappanavar, R., & Perlman, S. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0629-x · Cited by 2,524
Coronaviruses — drug discovery and therapeutic options
Zumla, A., Chan, J. F. W., Azhar, E. I., Hui, D. S. C., & Yuen, K.-Y. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.37 · Cited by 1,707
Middle East respiratory syndrome
Zumla, A., Hui, D. S., & Perlman, S. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60454-8 · Cited by 1,263
MERS, SARS and other coronaviruses as causes of pneumonia
Yin, Y., & Wunderink, R. G. (2018) · Respirology · doi:10.1111/resp.13196 · Cited by 1,095
Metadata
- Authors
- Al-Tawfiq, J. A., Momattin, H., Dib, J., & Memish, Z. A.
- Venue
- International Journal of Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2014-03
- Volume
- 20
- Pages
- 42-46
- ISSN
- 1201-9712 (ISSN-L)
- OpenAlex
- W2035958898
- Cited by
- 322
- References
- 24
- FWCI
- 24.23
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.